MediPal Holdings Corp:企業の戦略・SWOT・財務情報

◆英語タイトル:MediPal Holdings Corp - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C5776
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:一般ビジネス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

MediPal Holdings Corp – Strategy, SWOT and Corporate Finance Report
Summary

MediPal Holdings Corp – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

MediPal Holdings Corporation (MediPal or ‘the group’) is a Japan-based business group primarily engaged in the wholesale distribution of pharmaceutical products, cosmetics, and daily necessities. The group primarily operates in Japan, where it is headquartered in Tokyo.

Scope

- Detailed information on MediPal Holdings Corp required for business and competitor intelligence needs
- A study of the major internal and external factors affecting MediPal Holdings Corp in the form of a SWOT analysis
- An in-depth view of the business model of MediPal Holdings Corp including a breakdown and examination of key business segments
- Intelligence on MediPal Holdings Corp’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about MediPal Holdings Corp, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of MediPal Holdings Corp and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess MediPal Holdings Corp as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on MediPal Holdings Corp’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
MediPal Holdings Corp: Company Overview 9
MediPal Holdings Corp: Overview and Key Facts 9
MediPal Holdings Corp: Overview 9
MediPal Holdings Corp: Key Facts 9
MediPal Holdings Corp: Key Employees 11
MediPal Holdings Corp: Key Employee Biographies 13
MediPal Holdings Corp: Major Products and Services 18
MediPal Holdings Corp: Company History 19
MediPal Holdings Corp: Management Statement 22
MediPal Holdings Corp: Locations and Subsidiaries 25
MediPal Holdings Corp: Key Competitors 27
MediPal Holdings Corp: Company Analysis 28
MediPal Holdings Corp: Business Description 28
MediPal Holdings Corp: SWOT Analysis 29
MediPal Holdings Corp: SWOT Overview 29
MediPal Holdings Corp: Strengths 29
MediPal Holdings Corp: Weaknesses 30
MediPal Holdings Corp: Opportunities 30
MediPal Holdings Corp: Threats 31
MediPal Holdings Corp: Corporate Financial Deals Activity 32
MediPal Holdings Corp: Financial Deals Overview 32
MediPal Holdings Corp: Targets and Partners 33
MediPal Holdings Corp: Top Deals 2014 – 2018YTD* 34
MediPal Holdings Corp: Mergers and Acquisitions 35
MediPal Holdings Corp: Partnership 36
MediPal Holdings Corp: Recent Developments 37
MediPal Holdings Corp: News and Events Summary 37
MediPal Holdings Corp: Financial Performance 37
Appendix 38
Contact Us 38
Methodology 38
About MarketLine 39

List of Tables
Table 1: MediPal Holdings Corp: Key Facts
Table 2: MediPal Holdings Corp: Key Employees
Table 3: MediPal Holdings Corp: Company History
Table 4: MediPal Holdings Corp: Locations and Subsidiaries
Table 5: MediPal Holdings Corp: Key Competitors
Table 6: MediPal Holdings Corp: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: MediPal Holdings Corp: M&A Average Deal Size - Value (US$m)
Table 8: MediPal Holdings Corp: Targets and Partners
Table 9: MediPal Holdings Corp: Top Deals 2014 - 2018YTD*
Table 10: MediPal Holdings Corp: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: MediPal Holdings Corp: M&A Activity by Geography (2014 - YTD*2018)
Table 12: MediPal Holdings Corp: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 13: MediPal Holdings Corp: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 14: MediPal Holdings Corp: News and Events Summary
Table 15: MediPal Holdings Corp: Financial Performance

List of Figures
Figure 1: MediPal Holdings Corp: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: MediPal Holdings Corp: M&A Average Deal Size - Value (US$m)
Figure 3: MediPal Holdings Corp: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: MediPal Holdings Corp: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: MediPal Holdings Corp: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 6: MediPal Holdings Corp: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[MediPal Holdings Corp:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tata Consultancy Services Limited:企業の戦略・SWOT・財務情報
    Tata Consultancy Services Limited - Strategy, SWOT and Corporate Finance Report Summary Tata Consultancy Services Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Interpace Diagnostics Group Inc (IDXG):医療機器:M&Aディール及び事業提携情報
    Summary Interpace Diagnostics Group Inc (Interpace Diagnostics), formerly PDI Inc is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathfinder platform. It …
  • Tokyo Electric Power Company Holdings Incorporated (9501):電力:M&Aディール及び事業提携情報
    Summary Tokyo Electric Power Company Holdings Incorporated (TEPCO) is an energy utility. It generates, transmits and distributes electricity; transports fuel; and retails electricity and gas. The company produces power using coal, gas, LNG, solar, wind and hydro sources. TEPCO has presence in the en …
  • Navayuga Infotech Pvt. Ltd.:企業の戦略的SWOT分析
    Navayuga Infotech Pvt. Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Nampak Limited:企業の戦略・SWOT・財務情報
    Nampak Limited - Strategy, SWOT and Corporate Finance Report Summary Nampak Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Huawei Technologies Co Ltd:企業の戦略的SWOT分析
    Huawei Technologies Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Orkuveita Reykjavikur:電力:M&Aディール及び事業提携情報
    Summary Orkuveita Reykjavikur (Orkuveita) is a public utility company that provides electricity and water. The company generates and supplies electricity. It harnesses hot water from geothermal fields and supplies it for heating applications. The company also supplies cold water from its groundwater …
  • MAGNA Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MAGNA Pharmaceuticals Inc (Magna) is a pharmaceutical company that offers non-prescription products and prescription products. The company offers dietary supplement, nasal decongestant and drowsiness antihistamine for the treatment of allergy and upper respiratory symptoms. It provides omega …
  • ZESCO Ltd:企業の戦略的SWOT分析
    ZESCO Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Open Text Corporation (OTEX):企業の財務・戦略的SWOT分析
    Open Text Corporation (OTEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • SMU S.A. (SMU):企業の財務・戦略的SWOT分析
    SMU S.A. (SMU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Empresa Electricidad del Peru SA (ELECPBC1):企業の財務・戦略的SWOT分析
    Empresa Electricidad del Peru SA (ELECPBC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • United Continental Holdings Inc:戦略・SWOT・企業財務分析
    United Continental Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary United Continental Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Hankyu Hanshin Holdings, Inc.:企業の戦略・SWOT・財務情報
    Hankyu Hanshin Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hankyu Hanshin Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Zhejiang Hisoar Pharmaceutical Co Ltd (002099):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Hisoar Pharmaceutical Co Ltd (Hisoar) is a pharmaceutical company that offers specialty raw materials, preparations, fine chemicals, dyes and intermediates. The company offers raw drugs such as antibody, anti-virus, sugar-reducing, cardiovascular and worm-driven drugs. It produces f …
  • CeraPedics Inc-医療機器分野:企業M&A・提携分析
    Summary CeraPedics Inc (Cerapedics) is a provider of osteobiologic treatment solutions. The company’s products include i-factor putty and i-factor flex. Its i-factor putty is a biologic bone graft that uses a unique small peptide attachment factor to target specific integrins in osteogenic cells to …
  • Yanmar Co Ltd:企業の戦略的SWOT分析
    Yanmar Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Excision BioTherapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Excision BioTherapeutics Inc (Excision BioTherapeutics) is a developer of gene editing therapeutics for the treatment of infectious diseases. The company’s products comprise EBT101, a HIV CRISPR Cas9 gRNA multiplex biologic for the prevention of Human Immunodeficiency Virus; EBT103, a PML JC …
  • Discovery Communications, Inc.
    Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Fifth Third Bancorp:企業のM&A・事業提携・投資動向
    Fifth Third Bancorp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fifth Third Bancorp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆